Showing posts with label Leprosy in Children. Show all posts
Showing posts with label Leprosy in Children. Show all posts

Wednesday, June 22, 2011

On NO account should the mother stop breast feeding

Leprosy Mailing List – June 5th, 2011
Ref.:   On NO account should the mother stop breast feeding.
From: B Naafs, Munnekeburen, The Netherlands

Dear Salvatore,

I fully support Lysbeth Duncan (LML June 5th).  I would like to add that Dr Al Aboud (LML June 3rd) must also continue the dapsone though many sites warn against it.  There is no conclusive evidence that it harms the baby when it does not harm the mother.

Thanks for this discussion.

Dr Ben Naafs

On NO account should the mother stop breast feeding

Leprosy Mailing List – June 5th, 2011
Ref.:   On NO account should the mother stop breast feeding.
From: M E Duncan, Peebles, Scotland, UK

Dear Dr Noto,
Thank you to Dr Al Aboud for is message (LML June 3rd, 2011) inquiring about recommendations for breastfeeding in mothers with leprosy.  Herewith are a few brief comments.
In the pre-antibiotic era, Pedley [Nepal] published finding of M. leprae in breast milk.  For women on treatment, especially on clofazimine, clofazimine passes freely into breast milk.  Clofazimine is lipophillic.  The mother should be advised that if the babe regurgitates milk, the milk may be the colour of strawberry icecream!  This is normal and is evidence that the mother is taking her clofazimine and will protect the baby. The baby's skin may also become pigmented.  The pigmentation will fade after the baby is weaned.  On NO account should the mother stop breast feeding.  The baby is far more likely to die of gastroenteritis [D&V] if he is bottle fed which is a tragedy.
Lysbeth Duncan
Dr M E Duncan

Are there recommendations about breastfeeding for mothers with leprosy?

Leprosy Mailing List – June 3rd, 2011
Ref.:   Are there recommendations about breastfeeding for mothers with leprosy?
From: K Al Aboud, Makkah, Saudi Arabia

Dear Dr Noto,
I think that babies should not be separated from mothers and it is sufficient that mothers with leprosy get the anti-leprosy treatment.  However, what is the risk of transmission of leprosy from untreated mother to baby?  I suppose that the leprosy bacilli can pass through the milk or via the intimate contact (and hence, respiratory route) from mother to baby.  Is there a scientific base for advising the mother with leprosy, not to breast fed their babies because of the risk of transmission of leprosy?
There are some aspects to be mentioned for example: secretion of leprosy medications in the breast, nutritional deficiency in the babies if not breast fed, precipitation of reaction in this physiological period.  I can find one reference in the MEDLINE documenting this.  Duncan ME, Melsom R, Pearson JM, Menzel S,Barnetson RS. A clinical and immunological study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancy.  Int J Lepr Other Mycobact Dis 1983 Mar 51(1):7-17.

However, I wish to hear from our LML Panel, if there is a current recommendation regarding this matter by scientific societies or organization like WHO.

With respect and regards,

Dr Khalid Al Aboud
Consultant Dermatologist, King Faisal Hospital, Makkah, Saudi Arabia.
amoa65(at)hotmail.com
alaboudkhalid(at)yahoo.ca

Friday, June 4, 2010

Feeding 25 mg dose of clofazimine daily to a 2 year baby

Leprosy Mailing List – May 10th , 2010

Ref.: Feeding 25 mg dose of clofazimine daily to a 2 year baby
From: H K Kar, New Delhi , India




Dear Dr Saba,

I refer to your message dated May 9th, 2010. Your problem of feeding 25 mg dose of clofazimine daily to a 2 year baby is a genuine concern due to non availability of 25mg capsule as well as liquid preparation. The drug is not water-soluble, hence micronised crystals are suspended in an oil-max base and encapsulated in soft gelatin for oral administration. The absorption in this form is even only 30% to 50%.

As suggested by other LML members, you can feed 50 mg weekly twice. The soft gelatine capsule can be punctured and the oil-wax based clofazimine can be expressed from the capsule into a half teaspoon full of honey which can easily be fed to the baby twice a week, same way the monthly pulse dose also.

Regards,

Dr (Prof.) H K Kar
Consultant & HOD
Department of Dermatology, STD & Leprosy
P.G.I.M.E.R. and Dr Ram Manohar Lohia Hospital
Baba Kharag Singh Marg
New Delhi-110001

Multi-drug therapy (MDT) dosages in Ethiopian guidelines

Leprosy Mailing List – May 10th , 2010

Ref.: Multi-drug therapy (MDT) dosages in Ethiopian guidelines
From:
E. Kebede, Addis-Ababa , Ethiopia




Dear Dr Naafs,

Thank you for the clarification (your message dated LML May 9th, 2010). I have attached, herewith a PDF file from the National (Ethiopian) guidelines on leprosy management in adults and children. In the document are reported the dosages we recommend.

Best regards,

Dr. Eshetu Kebede

Director of Training Division

ALERT

E-mail: leprosytb(at)ethionet.et

Tel. +251 11 321 13 41/51

Fax: +251 11 321 13 51

MDT in a 2 year old child

Leprosy Mailing List – May 9th , 2010

Ref.: MDT in a 2 year old child
From: I. Kahawita , Sri Lanka


Dear Saba ,

ILEP Guidelines advise to give daily dapsone 25mg (the halved 50mg tablet as Dr Naafs has suggested) and clofazimine 50 mg twice weekly. I Hope this will be of use.

Yours sincerely,

Indira Kahawita

MDT in a 2 year old child

Leprosy Mailing List – May 9th , 2010

Ref.: MDT in a 2 year old child
From: B. Naafs, Munnekeburen, The Netherlands


Dear Dr Saba,

The dapsone tablet can be halved, if each halve contains slightly less it does not matter. Clofazimine is '"stored" in the adipose tissues. I would give each alternate day a clofazimine capsule.

With kind regards,

Dr Ben Naafs

ex-ALERT

Small child MDT - please advise

Leprosy Mailing List – May 9th , 2010

Ref.: Small child MDT - please advise
From: Saba Lambert, Addis Ababa , Ethiopia


Dear LML members,

I would be grateful if you could advice me on a case I have come across at ALERTHospital in Addis Ababa , Ethiopia .

The patient is a 2 year old child, weight 9kg, brought it for a check up by family. The father was diagnosed as a lepromatous case 7 months ago at our clinic with BI: 5,5,5. He is on his 7th month of MDT. They live in a rural environment about 8 hours travel from Addis.

The child was found to have a few nodules on the face, arms and buttocks. Her BI is 3,2,1.

The problem I have is with the treatment to give her. We have no low does medication inEthiopia and depend on the WHO packs of MDT (adult and child 10-14). For her 9kg she would need a monthly dose of Rifampicin 150mg, Clofazimine 25 mg and Dapsone 25mg, and a daily dose of dapsone 25mg and every other day dose of clofazimine 25mg. Form the child MDT pack, we have Rifampicin 150mg available but the dapsone and clofazimine come only in 50 mg tablets and blisters respectively.

Would you have any suggestions of how I can adjust her treatment?

I am grateful for you suggestions.

Dr Saba Lambert

Wednesday, February 4, 2009

Ofloxacin in leprosy

Leprosy Mailing List, January 18th, 2009

Ref.: Ofloxacin in leprosy
From: Saunderson P., Greenville , SC , USA


Dear Salvatore,

In response to Dr Kamaladasa’s question (LML Jan. 11th, 2009) about ofloxacin, the recommended dose for the treatment of leprosy is clearly stated by the WHO Expert Committee on Leprosy (Seventh Report, 1998; page 13) as 400mg daily. Monthly rifampicin, plus daily ofloxacin (400mg) for 6 months will be more than adequate for PB cases.

The fluoroquinolones, including ofloxacin, are not recommended for children and adolescents, because of possible effects on growing joints (arthropathy is seen in studies using immature animals). The WHO report also states: “Side effects include nausea, diarrhoea and other gastrointestinal complaints, and a variety of central nervous system complaints including insomnia, headaches, dizziness, nervousness and hallucinations. Serious problems are rare and do not usually require discontinuing the drug.”

With best wishes,

Dr Paul Saunderson, MD, MRCP
Medical Director: American Leprosy Missions
Head Office: 1 ALM Way, Greenville , SC 29601 , USA
Home address: Østrem, 6013 Ålesund , Norway
Email: psaunderson at leprosy.org

Monday, November 10, 2008

Leprosy in childhood

Leprosy Mailing List, November 2nd, 2008

Ref.: 'Leprosy in childhood'
From: Erlings J., Amsterdam, The Netherlands


Dear Dr Noto,
As there has been quite some interest in 'leprosy in childhood' lately I have now placed a reference list on this subject on the Infolep website:
http://www.ilep.org.uk/library-resources/infolep-information-services/subjectguides/leprosy-in-childhood/The list includes references from 1998-2008 and some links to free full text publications.
I hope to add reference lists on other popular subjects soon. Suggestions for subjects can be e-mailed to infolepatleprastichting.nl

With kind regards,
Jiske Erlings
INFOLEP Leprosy Information Services

Thursday, October 16, 2008

Leprosy in children

Leprosy Mailing List – October 6th, 2008

Ref.: Leprosy in children (see attachment)
From: Naafs B., Munnekeburen, The Netherlands


Dear Salvatore,

Concerning Dr Deepak's request (LML Sept 5th 2008):- I gave a talk over 10 years ago in Jaipur at a Paediatric conference and later published the content of that talk in a Dutch teaching journal Memisa Medisch. Find enclosed the text I hope it may be useful.
At that time I had little experience in leprosy in children in Brazil. There they have a nodular form of leprosy in children. I have looked for a paper on this specific subject, which can be found with Google: “Nodular leprosy of childhood and tuberculoid leprosy: A comparative, morphologic, immunopathologic and quantitative study of skin tissue reaction”. International Journal of Leprosy and Other Mycobacterial Diseases, Sep 2003 by Fakhouri, Ricardo, Sotto, Mirian N, Manini, Marli I P, Margarido, Leontina C
Ben

<< Naafs B 2008 10 04 Leprosy in children >>

Friday, October 3, 2008

Leprosy in children

Leprosy Mailing List - September 23rd, 2008

Ref.: Leprosy in children (see attachment)
From: Erlings J., Amsterdam, The Nethelands



Dear Dr Noto,

I would like to refer to Dr Deepak's message about literature on leprosy in children (LML Sep. 5th, 2008).

Attached to this e-mail you will find the results of a literature search I did earlier this year on this topic. Anyone interested in receiving full text copies of selected articles may contact me by e-mail at <<>infolepatleprastichting.nl >>.

With kind regards,
Jiske Erlings
INFOLEP Leprosy Information Services

Friday, September 12, 2008

Leprosy Mailing List, September 11th, 2008

Ref.: Leprosy in children and INFOLEP
From: v Brakel W., Amsterdam, The Netherlands

Dear Salvatore,

I refer to Dr Sunil Deepak LML message dated Sept. 5th 2008. I have already written a specific suggestion to Sunil, but would like to remind LML readers that such requests for articles, etc. can also be addressed to the now joint ILEP/NLR resource centre INFOLEP. Requests should be addressed to:
infolep@leprastichting.nl.
More information about INFOLEP and its resources can be found on the new ILEP website: www.ilep.org.uk.

With best wishes,

Wim van Brakel

KIT Leprosy Unit
w.v.brakelatkit.nl

Leprosy in children

Leprosy Mailing List, September 11th, 2008

Ref.: Leprosy in children
From: Faria Rodrigues C. A., Passos, MG, Brazil

Dear Salvatore,
I think many of us around the world like Dr Sunil Deepak (LML Sep. 5th, 2008) have the same problem with “leprosy in children” and those monographs and articles he asked for, on this theme will be useful to all of us.
Thanks.
With best wishes,
Dr Carlos Alberto Faria Rodrigues
Av. Arouca 660 Sala 1014 – Passos – Minas Gerais – BrazilTel: +55 (35) 3521-7811Email dermorlatpassosnet.com.br Webpage: www.hanseniase2.passosuemg.br

Leprosy in children

Leprosy Mailing List, September 11th, 2008

Ref.: Leprosy in children
From: Ryan T., Oxford, UK


Dear Salvatore,
I refer to Dr Deepak’s LML message dated Sept. 5th, 2008. Very important to emphasise that anything that switches on repair of the epidermis accelerates its cell turnover and melanisation may not be able to keep up. Mild dermatitis is very common due a range of climate effects, infections and irritants. It results in hypopigmentation, so white patches in children are common (Pityriasis alba) and respond to emollients. Sweating is not pronounced in children and therefore its absence un helpful. The memory of leprosy has to be sown in every medical student and of course the basic skill of sensory testing.

In Children, facial pityriasis alba cannot so easily be distinguished since the facial innervation defects in leprosy white patches in children are difficult to define. One hesitates to biopsy a child's face but persistent white patches else where on the body, not responding to emollients or antifungals should be biopsied. As has been pointed out by Margaret Lockwood in the UK the memory of leprosy is often triggered by the Dermatologists habit of taking a biopsy.

This is a preface to ask you not to focus on this rare disease out of context of the many other causes of skin disease but to emphasise the importance of the skin, its barrier function, communication role, themoregulation, and sensory function and encourage them to avoid the ignorance that prevails world wide on how to manage it.

Most of dermatology's textbooks and Internet are well equipped to answer questions on the diagnosis of skin lesions in Children. Think of leprosy should be the main teaching point.

Terence Ryan

Leprosy in children

Leprosy Mailing List, September 5th, 2008

Ref.: Leprosy in children
From: Deepak S., Bologna, Italy


Dear Salvatore,

I need to prepare a lesson for medical students on "Leprosy in children". I shall be grateful if we can receive any monographs or articles or bibliography on this theme from the LML readers.

The documents can be sent to LML or directly to my email: sunil.deepakataifo.it

Thanks in advance to all the LML readers who can help us and with best wishes,

Sunil

Dr Sunil Deepak
Head, Medical Support Department
AIFO
Via Borselli 4-6
40135 - Bologna
Italy
Tel: +39051 - 4393211 / 4393219 (Direct)
Fax: +39051 - 434046
Webpage: www.aifo.it/english/

Monday, June 30, 2008

High case detection of leprosy in Pando, Bolivia

Leprosy Mailing List, June 19th, 2008

Ref.: High case detection of leprosy in Pando, Bolivia
From: Villarreal Olaya M. E., La Paz, Bolivia


Dear Dr Noto,
Thank you very much to Dr Eggens for translating the summary of our paper in English (LML 15th, 06 2008) and, for his comments (LML 17th, 06 2008). Certainly, the detection percentage in Pando is very high, this can explain to you because during the last two decades they had registered per year around 1 to 2 patients. Because the leprosy programme in Pando didn't work, there have never been carried out activities of active search, the reason is the personnel that works in Pando don't have the due training in leprosy and therefore they didn't show interest.

The year 2007-2008 with the cooperation of an ONG COINFA were carried out campaigns of dermatologist attention with the purpose of finding cases of leprosy, and we registered all that are informed in the paper, this organization it had not considered in its budget the follow up of the patients, control of the domiciliary focus neither the disabilities prevention.

For that a great quantity of patients has not continued their treatment, no exist personnel qualified in follow up and lack of economic resources to be able to move to the rural areas where they have registered the cases.

In November arrived to Cobija (Pando) a commission from Brazil headed by the Dr. Wood who is expert in leprosy to verify the realized diagnoses, he congratulated the work that has been carried out.

Bolivia is neighbouring with Brazil in a great extension; the data that were reported until 2005 not showed our true reality, I consider that we should begin to work and to admit our reality, that we have leprosy in Bolivia.
Best regards,
Dra. Maria Esther Villarreal O.
La Paz, Bolivia

Child leprosy in Pando Department, Bolivia

Leprosy Mailing List, June 17th, 2008

Ref.: Child leprosy in Pando Department, Bolivia
From: Eggens H., Amsterdam, the Netherlands

Dear Salvatore,

Thank you for forwarding Dr Villarreal's article on child leprosy in Pando Department, Bolivia (LML June 15th, 2008). Please find below my brief comment.

I find it remarkable: with a Pando department population of around 67,000 (2005), an annual leprosy case detection rate (March 2007-Feb 2008) of 202/67000 = around 300/100,000 is enormous! A child proportion of 28% is also out of the ordinary. What is happening there? We know that in neighbouring Rondonia, Brazil, high case detection rates are reported for many years (80/100,000 in 2006).

Kind regards,

Henk

Henk Eggens, MD MPHSenior adviser public healthRoyal Tropical InstituteAmsterdam, The Netherlands

English summay of: "Leprosy in children in Pando Department, Bolivia"

Leprosy Mailing List, June 15th, 2008

Ref.: English summay of: "Leprosy in children in Pando Department, Bolivia"
From: Eggens H., Amsterdam, The Netherlands
Dear Salvatore,
I have translated the summary of Dr Villarreal's article on child leprosy in Pando Dept., Bolivia. Please find it below. A short comment of mine will follow with the next message. Greetings.
Henk
Henk Eggens, MD MPHSenior adviser public healthRoyal Tropical InstituteAmsterdam, The Netherlands


Epidemiological leprosy situation in children under 15 years of age in Pando Department, Bolivia
Villarreal,M.E*.; Bustillos,J**.; Rios, L***.; Iquize,C***.; Franco,M.C***.; Isita,D.***
(* Dermatologist COINFA,** Director COINFA,*** Personal SEDES Pando.)

Summary:
Leprosy in children is an infrequent disease; its diagnosis requires good clinical skills. It is difficult to diagnose in children under 14 years of age, because its appearance is limited to maculae that can be overlooked or can be confounded with another disease.

Objective:
The objective of this study was to analyse the epidemiological leprosy situation in children under 15 years in Pando Department. A retrospective descriptive study was used as study design, with clinical histories as basis for information. Fifty-eight clinical histories were studied; age, sex, initial skin lesion, patient delay and clinical appearance were analysed.

Results:
In the period of March 2007-February 2008, 202 new leprosy cases were registered in Pando Department. Fifty-eight of them were children under 15 years of age, 20 boys and 38 girls. Eighty-four percent presented maculae, most frequently in the face (33%). The most common clinical presentation was indeterminate (54%). Eighteen percent had Grade One disability and in 34 % a skin smear was taken. Clinical appearance and epidemiology were the pillars of diagnosis.

Conclusions:
Leprosy is among the re-emerging diseases in our country and worldwide. Child leprosy is not limited to clinical disease characteristics, but is linked to epidemiology, public health and health education. Child leprosy is a direct indicator of the magnitude of disease transmission and of the effectiveness of control programme activities, in the sense that it reflects an important active transmission and a low coverage of activities of case detection and early treatment.

Leprosy in children in Pando Province, Bolivia

Leprosy Mailing List, June 15th, 2008

Ref.: Leprosy in children in Pando Province, Bolivia (Spanish)
From: Villarreal M. E., La Paz, Bolivia
Dear All,
In attachment is the interesting paper of Dr Villarreal et al. I would be very grateful if somebody could translate it in English.
Best regards,
S. Noto


Dear Dr. Noto, Le envío el artículo de la Revista Dermatológica Boliviana sobre los casos encontrados en el Departamento de Pando en Bolivia. Como mi Inglés no es fluido, espero que pueda traducirlo. Sinceramente, Dra. Maria Esther Villarreal O.La Paz, Bolivia